{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-269493","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2026-06-12T20:19:09+00:00","discovered_at":"2026-06-12T20:20:02.359560+00:00","generated_at":"2026-06-12T20:39:04.119583+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Whitehawk Therapeutics shareholders elect three Class III directors at annual meeting","bullets":["Behzad Aghazadeh, Richard Maroun, and Emma Reeve elected as Class III directors with 26.7M, 27.7M, and 27.7M votes for, respectively.","Advisory say-on-pay passed with 22.9M for, 6.0M against, 3.6M abstain.","Ratification of BDO USA as auditor for FY 2026 passed with 34.8M for, 1.1M against, 4.4M abstain.","Approximately 82% of voting power (40.4M shares) present, constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-269493","json":"https://secwatch.observer/filing/0001193125-26-269493.json","markdown":"https://secwatch.observer/filing/0001193125-26-269493.md","text":"https://secwatch.observer/filing/0001193125-26-269493.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/whwk-20260611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:39:04.119583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29120d9a0cf83cdc915b9daafb7dcabae47cb128","claim":"Whitehawk Therapeutics, Inc. shareholders approved Election of three Class III directors at the 2026-06-11 meeting.","evidence_excerpt":"Behzad Aghazadeh, Ph.D. 26,666,124 5,867,225 7,841,674 Richard Maroun 27,701,332 4,832,017 7,841,674 Emma Reeve 27,704,564 4,828,785 7,841,674","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"446c39a4ae0a02e12e214fab880cdc290f54a919","claim":"Whitehawk Therapeutics, Inc. shareholders approved Ratification of BDO USA, P.C. as independent registered public accounting firm at the 2026-06-11 meeting.","evidence_excerpt":"Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstentions 34,795,850 1,148,282 4,430,891","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"71360f5aa8fcc779e5c34a838ce0edd8ba70d811","claim":"Whitehawk Therapeutics, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-11 meeting.","evidence_excerpt":"Proposal 2: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the “Executive Compensation” section of the Proxy Statement. For Against Abstentions Broker Non-Votes 22,896,061 6,013,600 3,623,688 7,841,674","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422142/000119312526269493/0001193125-26-269493-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}